Scott B. Phillips insider trades: Winston Pharmaceuticals (WPHM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Scott reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 16, 2009 | WPHM | ↓ Sell | 20,000 | $0.64 | $13K | Direct | Oct 19, 2009 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Scott B. Phillips's insider trades
Scott B. Phillips is SVP, Scientific Affairs at Winston Pharmaceuticals (WPHM). Since Oct 16, 2009, Scott has reported no open-market purchases and 1 sale worth $13K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WPHM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.